Modulari-T Patents

Patent portfolio assigned to Modulari-T (verified via public assignee records). Modulari-T Bioscience - modular/universal CAR-T cell therapy; proprietary MARC (Modular Antigen Receptor Complex) receptor and MoVe platform described as patented/proprietary on own site; founders authored MARC research (PMID 40254394). Listed HQ Montreal, Canada (dataset says US - country mismatch but clearly same biotech). has_patents=true from proprietary-patent claims; exact count unverified (Google Patents returned 503 all attempts). Preclinical biotech: no customers (not a customer business).